X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (145) 145
female (131) 131
index medicus (101) 101
oncology (83) 83
middle aged (70) 70
cancer (66) 66
aged (60) 60
adult (53) 53
cell line, tumor (46) 46
article (40) 40
obstetrics & gynecology (40) 40
animals (39) 39
chemotherapy (36) 36
male (36) 36
expression (35) 35
carcinoma (34) 34
ovarian cancer (34) 34
mice (33) 33
flow cytometry (29) 29
immunotherapy (29) 29
immunohistochemistry (28) 28
tumors (27) 27
mutation (26) 26
care and treatment (24) 24
endometrial cancer (24) 24
obstetrics and gynecology (24) 24
research (24) 24
genetic aspects (22) 22
cervical cancer (21) 21
gene expression (21) 21
abridged index medicus (20) 20
identification (19) 19
ovarian neoplasms - metabolism (18) 18
trastuzumab (18) 18
uterine neoplasms - drug therapy (18) 18
dendritic cells (17) 17
diagnosis (17) 17
ovarian neoplasms - drug therapy (17) 17
prognosis (17) 17
uterine serous carcinoma (17) 17
breast-cancer (16) 16
uterine neoplasms - genetics (16) 16
uterine neoplasms - metabolism (16) 16
vaccination (16) 16
xenograft model antitumor assays (16) 16
adolescent (15) 15
aged, 80 and over (15) 15
analysis (15) 15
antineoplastic agents - pharmacology (15) 15
cystadenocarcinoma, serous - drug therapy (15) 15
hematology, oncology and palliative medicine (15) 15
her2/neu (15) 15
tumor cells, cultured (15) 15
antigens, neoplasm - immunology (14) 14
dendritic cells - immunology (14) 14
genes (14) 14
health aspects (14) 14
in-vitro (14) 14
ovarian neoplasms - pathology (14) 14
drug resistance, neoplasm (13) 13
endometrial carcinoma (13) 13
her2 (13) 13
mice, scid (13) 13
receptor, erbb-2 - genetics (13) 13
risk factors (13) 13
uterine cervical neoplasms - immunology (13) 13
uterine neoplasms - pathology (13) 13
cells (12) 12
cystadenocarcinoma, serous - genetics (12) 12
gene expression regulation, neoplastic (12) 12
ovarian neoplasms - genetics (12) 12
ovarian neoplasms - immunology (12) 12
peptides (12) 12
resistance (12) 12
rna, messenger - genetics (12) 12
biomarkers (11) 11
cell adhesion molecules - immunology (11) 11
child (11) 11
cystadenocarcinoma, serous - metabolism (11) 11
development and progression (11) 11
endocrinology & metabolism (11) 11
gene amplification (11) 11
metastasis (11) 11
mutations (11) 11
t-lymphocytes, cytotoxic - immunology (11) 11
uterine cancer (11) 11
antibodies (10) 10
cell proliferation - drug effects (10) 10
immunology (10) 10
neoplasm staging (10) 10
neoplasms. tumors. oncology. including cancer and carcinogens (10) 10
neu (10) 10
overexpression (10) 10
pediatrics (10) 10
reverse transcriptase polymerase chain reaction (10) 10
t cells (10) 10
uterine cervical neoplasms - pathology (10) 10
antibodies, monoclonal - pharmacology (9) 9
antineoplastic agents - therapeutic use (9) 9
cancer research (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer, ISSN 0008-543X, 12/2011, Volume 117, Issue 24, pp. 5519 - 5528
Journal Article
BMC Cancer, ISSN 1471-2407, 07/2010, Volume 10, Issue 1, pp. 349 - 349
Background: Development of innovative, effective therapies against recurrent/chemotherapy-resistant ovarian cancer remains a high priority. Using... 
CLAUDIN-4 | DIAGNOSIS | EPITHELIUM | ONCOLOGY | CANDIDATE MOLECULAR MARKERS | GENE-EXPRESSION PROFILES | EARLY-STAGE | RECEPTOR | IDENTIFICATION | CARCINOMA | Carcinoma, Papillary - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Cystadenocarcinoma, Serous - metabolism | Cercopithecus aethiops | Drug Resistance, Neoplasm | Peptide Fragments - pharmacology | Transplantation, Heterologous | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - drug therapy | Carcinoma, Papillary - metabolism | Clostridium perfringens | Ovarian Neoplasms - genetics | Tissue Distribution | Adenocarcinoma - metabolism | Flow Cytometry | Uterine Cervical Neoplasms - metabolism | Fibroblasts | Female | Adenocarcinoma - genetics | Membrane Proteins - metabolism | Ovarian Neoplasms - metabolism | Spheroids, Cellular - drug effects | Tumor Cells, Cultured | Ovarian Neoplasms - drug therapy | Vero Cells | Adenocarcinoma, Clear Cell - metabolism | Membrane Proteins - genetics | RNA, Messenger - genetics | Peptide Fragments - pharmacokinetics | Carcinoma, Papillary - drug therapy | Uterine Cervical Neoplasms - drug therapy | Mice, SCID | Reverse Transcriptase Polymerase Chain Reaction | Uterine Cervical Neoplasms - genetics | Adenocarcinoma - drug therapy | Claudin-4 | Claudin-3 | Animals | Carcinoma, Squamous Cell - drug therapy | Mice | Adenocarcinoma, Clear Cell - genetics | Enterotoxins - pharmacology | Adenocarcinoma, Clear Cell - drug therapy | Clostridium | Chemotherapy | Enterotoxins | Physiological aspects | Genetic aspects | Research | Diagnosis | Drug therapy | Health aspects | Ovarian cancer | Cancer
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 01/2010, Volume 9, Issue 1, pp. 57 - 66
We evaluated the expression of epithelial cell adhesion molecule (EpCAM) and the potential of MT201 (adecatumumab), a human monoclonal antibody against EpCAM,... 
MT201 | Adecatumumab | Tumor markers | EpCAM | Endometrial carcinoma | Uterine serous papillary cancer | INTERLEUKIN-2 | SURVIVAL | NATURAL-KILLER-CELLS | IN-VITRO | CLEAR-CELL | ONCOLOGY | EP-CAM | OVARIAN-CANCER | EXPRESSION | CELL ADHESION MOLECULE | CLINICOPATHOLOGICAL FEATURES | Immunohistochemistry | Carcinoma, Papillary - genetics | Cell Adhesion Molecules - genetics | Uterine Neoplasms - pathology | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Cell Adhesion Molecules - immunology | Cystadenocarcinoma, Serous - genetics | Cystadenocarcinoma, Serous - pathology | RNA, Messenger - metabolism | Cystadenocarcinoma, Serous - drug therapy | Epithelial Cell Adhesion Molecule | Neoplasm Metastasis | Flow Cytometry | Immunotherapy | Immunoglobulin G - pharmacology | Killer Cells, Natural - immunology | Female | Cell Membrane - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Cell Membrane - drug effects | Uterine Neoplasms - genetics | Antigens, Neoplasm - genetics | Antigens, Neoplasm - immunology | RNA, Messenger - genetics | Carcinoma, Papillary - drug therapy | Carcinoma, Papillary - pathology | Uterine Neoplasms - drug therapy | Cell Line, Tumor | Interleukin-2 - pharmacology | Aged | Killer Cells, Natural - drug effects | Antibody-Dependent Cell Cytotoxicity - drug effects | Cell Adhesion Molecules - therapeutic use | Drug Resistance, Neoplasm - drug effects | Drug Screening Assays, Antitumor
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2013, Volume 110, Issue 8, pp. 2916 - 2921
Journal Article
Cancer, ISSN 0008-543X, 07/2011, Volume 117, Issue 14, pp. 3163 - 3172
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2016, Volume 113, Issue 43, pp. 12238 - 12243
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2016, Volume 113, Issue 41, pp. 11453 - 11458
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e83685
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2011, Volume 122, Issue 1, pp. 171 - 177
Abstract Objective. We evaluated the expression of human trophoblast cell-surface marker (Trop-2) and the potential of hRS7, a humanized monoclonal anti-Trop-2... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Chemotherapy-resistant | Trop-2 | Trophoblast cell-surface marker | Antibody-dependent cellular cytotoxicity | hRS7 | Ovarian cancer | INTERLEUKIN-2 | SPECIFICITY | MOLECULE | IDENTIFICATION | CANCER | OBSTETRICS & GYNECOLOGY | ONCOLOGY | DISEASE | EXPRESSION | Immunohistochemistry | Cell Adhesion Molecules - genetics | Immunoglobulin G - blood | Humans | Middle Aged | Antigens, Neoplasm - biosynthesis | Drug Resistance, Neoplasm | Cell Adhesion Molecules - immunology | Ovarian Neoplasms - genetics | RNA, Messenger - biosynthesis | Flow Cytometry | Interleukin-2 - immunology | Killer Cells, Natural - immunology | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Antibodies, Monoclonal - immunology | Molecular Targeted Therapy - methods | Antigens, Neoplasm - genetics | Antibody-Dependent Cell Cytotoxicity | Antigens, Neoplasm - immunology | Cell Adhesion Molecules - biosynthesis | Antibodies, Monoclonal - pharmacology | RNA, Messenger - genetics | Cell Line, Tumor | Interleukin-2 - pharmacology | Ovarian Neoplasms - immunology | Viral antibodies | Antibodies | Chemotherapy | Immunotherapy | Cancer | trophoblast cell surface marker | chemotherapy-resistant | antibody-dependent cellular cytotoxicity | ovarian cancer
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 2013, Volume 168, Issue 1, pp. R1 - R11
Objective: Subclinical hypothyroidism (SH) is quite common in children and adolescents. The natural history of this condition and the potential effects of... 
OBESE CHILDREN | RISK-FACTOR | THYROID-FUNCTION | L-THYROXINE TREATMENT | ENDOCRINOLOGY & METABOLISM | WEIGHT-LOSS | FOLLOW-UP | SUBDINICAL HYPOTHYROIDISM | CORONARY-HEART-DISEASE | HASHIMOTOS-THYROIDITIS | CHILDHOOD OBESITY
Journal Article
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 5, pp. 465.e1 - 465.e9
Journal Article